UBS Equities-China Equity Strategy _Parallels with the 2015-16 recovery -...-107141624

2024-03资本市场23免费

📄 文件全名: 《UBS Equities-China Equity Strategy _Parallels with the 2015-16 recovery -...-107141624.pdf》
🎯 适合读者: 投资人行业研究员
📊 核心数据: valuations. While the 2H15 episode saw a false start with the CSI 300 recovering 27%
Overseas exposures have risen to c.15% of revenue from 12.5% in 2015, while gearing
payout ratio is now at 33% vs 29% in 2015/2016 while trailing 12M buyback amount is
also at a historical high at RMB260bn (c.0.3% of market cap but much higher for the
drain on the equity markets. Earnings growth (8% for 2023 based on consensus
🏷️ 核心议题: #IPO

📦 本报告属于月份合集

购买后将获得「2024 年 3 月报告合集」 · 共 3061 份报告打包下载链接

点击获取云盘下载链接

报告摘要

Global Research and Evidence Lab Parallels with the 2015-16 recovery - what can we learn and what to do from here?

❓ 常见问题

《UBS Equities-China Equity Strategy _Parallels with the 2015-16 recovery -...-107141624》主要包含哪些内容?

Global Research and Evidence Lab Parallels with the 2015-16 recovery - what can we learn and what to do from here?核心数据:valuations. While the 2H15 episode saw a false start with the CSI 300 recovering 27%;Overseas exposures have risen to c.15% of revenue from 12.5% in 2015, while gearing;payout ratio is now at 33% vs 29% in 2015/2016 while trailing 12M buyback amount is。

这份报告覆盖哪一年、篇幅多大?

覆盖 2024 年,全文约 23。

这份报告是免费的吗?如何获取?

本报告免费查阅,登录资料宝后即可在线获取完整内容。

这份报告适合哪些读者?

适合投资人、行业研究员等读者参考。

报告涉及哪些关键议题?

重点分析了IPO等议题。